Suppr超能文献

腺苷脱氨酶抑制可预防缺血后心脏的自由基介导损伤。

Adenosine deaminase inhibition prevents free radical-mediated injury in the postischemic heart.

作者信息

Xia Y, Khatchikian G, Zweier J L

机构信息

Department of Medicine, Division of Cardiology, Johns Hopkins Medical Institutions, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA.

出版信息

J Biol Chem. 1996 Apr 26;271(17):10096-102. doi: 10.1074/jbc.271.17.10096.

Abstract

In the presence of its substrates hypoxanthine and xanthine, xanthine oxidase generates oxygen free radicals that cause postischemic injury. Recently, it has been demonstrated that the burst of xanthine oxidase-mediated free radical generation in the reperfused heart is triggered by a large increase in substrate formation, which occurs secondary to the degradation of adenine nucleotides during ischemia. It is not known, however, whether blocking this substrate formation is sufficient to prevent radical generation and functional injury. Therefore, studies were performed in isolated rat hearts in which xanthine oxidase substrate formation was blocked with the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA), and measurements of contractile function and free radical generation were performed. Chromatographic measurements of the intracellular adenine nucleotide pool showed that preischemic administration of EHNA blocked postischemic hypoxanthine, xanthine, and inosine formation. Electron paramagnetic resonance spin trapping measurements of free radical generation showed that inhibition of adenosine deaminase with EHNA blocked free radical generation and that it also increased the recovery of contractile function by more than 2-fold. Exogenous infusion of hypoxanthine and xanthine totally reversed the protective effects of EHNA. These results demonstrate that blockade of xanthine oxidase substrate formation by adenosine deaminase inhibition can prevent free radical generation and contractile dysfunction in the postischemic heart.

摘要

在其底物次黄嘌呤和黄嘌呤存在的情况下,黄嘌呤氧化酶会产生活氧自由基,从而导致缺血后损伤。最近有研究表明,再灌注心脏中黄嘌呤氧化酶介导的自由基生成激增是由底物生成的大幅增加引发的,这种增加继发于缺血期间腺嘌呤核苷酸的降解。然而,尚不清楚阻断这种底物生成是否足以防止自由基生成和功能损伤。因此,研究人员在离体大鼠心脏中进行了实验,用腺苷脱氨酶抑制剂赤式-9-(2-羟基-3-壬基)腺嘌呤(EHNA)阻断黄嘌呤氧化酶底物生成,并测量收缩功能和自由基生成。细胞内腺嘌呤核苷酸池的色谱测量结果显示,缺血前给予EHNA可阻断缺血后次黄嘌呤、黄嘌呤和肌苷的生成。自由基生成的电子顺磁共振自旋捕捉测量结果显示,用EHNA抑制腺苷脱氨酶可阻断自由基生成,并且还使收缩功能的恢复提高了2倍多。外源性输注次黄嘌呤和黄嘌呤完全逆转了EHNA的保护作用。这些结果表明,通过抑制腺苷脱氨酶阻断黄嘌呤氧化酶底物生成可预防缺血后心脏中的自由基生成和收缩功能障碍。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验